Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Qiagen NV QGEN

Technology Scientific & Technical Instruments
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic... see more

Recent & Breaking News (NYSE:QGEN)

QIAGEN Partners With Leading European Service Provider GATC Biotech to Offer Clients Full Access to Ingenuity Variant Analysis

PR Newswire March 19, 2015

QIAGEN Expands Leadership in Liquid Biopsies with New Circulating Tumor Cell Technology for Development of Companion Diagnostics

PR Newswire March 16, 2015

QIAGEN Collaborates With Allele Frequency Community to Advance Translational Medicine and Clinical Diagnostics

PR Newswire February 24, 2015

Largest-Ever Pivotal Study in China Supports QIAGEN's QuantiFERON®-TB Gold Over Tuberculin Skin Test for Latent Tuberculosis Infection

PR Newswire February 11, 2015

QIAGEN Reports Results for Fourth Quarter and Full-Year 2014

PR Newswire January 28, 2015

QIAGEN Introduces QuantiFERON Monitor® for Tracking Immune Function in Solid Organ Transplant Patients and for Research Into Other Applications

PR Newswire January 27, 2015

QIAGEN N.V. to Report Fourth Quarter and Full-Year 2014 Results

PR Newswire January 16, 2015

ArcherDX Launches from QIAGEN Acquisition of Enzymatics

Business Wire January 12, 2015

QIAGEN Announces First-ever Regulatory Registration of a Lung Cancer Companion Diagnostic Based on Liquid Biopsies

PR Newswire January 12, 2015

QIAGEN Acquires Enzymatics Enzyme Solutions Unit, a Leading Enabler of NGS Applications

PR Newswire January 11, 2015

QIAGEN Announces Offer to Repurchase Existing 2024 Convertible Notes

PR Newswire January 11, 2015

QIAGEN Exceeds 2014 Goal to Achieve 1,250 Cumulative QIAsymphony System Placements and Expands artus U.S. Test Menu

PR Newswire January 8, 2015

QIAGEN Launches QuantiFERON®-TB Gold Plus - A New Generation of the Most Accurate Test for Detecting Tuberculosis Infections

PR Newswire January 7, 2015

QIAGEN to Distribute altona Diagnostic's RealStar® Ebolavirus RT-PCR Kit 1.0, Recently Authorized by the FDA for Emergency Use

PR Newswire December 4, 2014

QIAGEN Signs Ninth Master Collaboration Agreement for Companion Diagnostics

PR Newswire November 11, 2014

QIAGEN Reports Results for Third Quarter and First Nine Months of 2014

PR Newswire October 29, 2014

QIAGEN Announces Broad Agreement With Astellas Pharma to Develop Companion Diagnostics

PR Newswire October 28, 2014

QIAGEN Applauds Inclusion of Screening and Treatment for Latent Infection in WHO's Post-2015 Global Strategy to End Tuberculosis

PR Newswire October 28, 2014

QIAGEN Demonstrates Expanded Bioinformatics Workflows at ASHG; Strong Market Adoption as Researchers Analyze Genomic Data on More Than a Quarter-Million Samples in Secure Private Cloud

PR Newswire October 17, 2014

Genomics England Names QIAGEN Bioinformatics One of the UK100K Project Assessment Winners

Business Wire October 14, 2014